| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |